Epidemiology and overview -- Type 1 diabetes mellitus: an overview -- An overview on type 2 diabetes -- Pathogenesis of type 2 diabetes-: a comprehensive analysis -- Managing the broad spectrum of type 2 diabetes -- Prediabetes: prevalence, pathophysiology and recognition of enhanced risk -- Obesity and type 2 diabetes in youths: new challenges to overcome -- Diabetes pathophysiology- a nutritional perspective -- Diabetes pathophysiology- a nurse's perspective -- Roles of environmental pollution and pesticides in the metabolic syndrome and diabetes: the epidemiological evidence -- Preventing diabetes with diet and exercise -- Types of diabetes and its correlation with other diseases -- The role of insulin resistance in the cardiorenal syndrome -- An overview on diabetic nephropathy -- An overview on diabetes and ocular health -- An overview on diabetic retinopathy -- Role of peripheral neuropathy in the development of foot ulceration and impaired wound healing in diabetes mellitus -- An overview on gestational diabetes -- Molecular insights of diabetes and metabolic syndrome -- Gene-environment interaction in the pathogenesis of type 2 diabetes -- Epigenetics in the pathophysiology of type 2 diabetes -- Targeting the metabolic syndrome and type 2 diabetes by preventing inflammation -- Interleukin-18 in metabolic syndrome and diabetes -- Pathophysiology -- Sleep, hypertension and diabetes -- Roles of pancreatic cell functions, liver, skeletal muscle and adipose tissues in diabetes and metabolic syndrome -- Liver disease: a neglected complication of diabetes mellitus -- Prevention and treatment 1: diet, exercise, supplements and alternative medicines -- Antioxidants, healthy diet and diabetes -- Molecular mechanisms of diabetes prevention by structurally diverse antioxidants -- Cardioprotective roles of selenium in diabetes -- Exercise and physical activity in the prevention of diabetes and metabolic syndrome -- An overview on nutraceuticals and herbal supplements for diabetes and metabolic syndrome -- Therapeutic effect of fucoxanthin on metabolic syndrome and type 2 diabetes -- Beneficial effects of chromium (iii) and vanadium supplements in diabetes -- Role of n-6 and n-3 polyunsaturated fatty acids in type 2 diabetes -- Effects of supplemental fiber in type 2 diabetes mellitus -- The effects of resveratrol on diabetes and obesity -- Meal plans for diabetics: caloric intake, calorie counting and glycemic index -- Ayurveda and metabolic diseases -- whole is greater than sum of parts -- Prevention and treatment 2: drugs and pharmaceuticals -- The evolution of glucose-lowering drugs for type 2 diabetes -- Anti-diabetic drugs for elderly population -- Diabetes in animals and treatment -- Diabetes mellitus in animals: diagnosis and treatment of diabetes mellitus in dogs and cats -- Overview of diabetes treatment in animals -- Living with diabetes: a running commentary.
Summary:
Diabetes mellitus affects approximately 20 million people in the US, or nearly 7% of the population. It is expected to increase by 70% within the next 25 years and numerous epidemiologic studies have demonstrated that type 2 diabetes increases the risk of cardiovascular morbidity and mortality. It is estimated to cost over $92 BILLION in health care costs and lost productivity. The increased risk is due to the detrimental vascular effects of prolonged exposure to a hyperglycemic, oxidant rich environment yielding associated cardiovascular risk factors: atherosclerosis, hypertension and clotting abnormalities. Hypertension and dyslipidemia in diabetic patients produces substantial decreases in cardiovascular and micro vascular diseases. Debasis Bagchi and Nair Sreejayan provides an overview of the current epidemic, outlines the consequences of this crisis and lays out strategies to forestall and prevent diabetes, obesity and other intricate issues of metabolic syndrome.
This resource is supported by the Institute of Museum and Library Services under the provisions of the Library Services and Technology Act as administered by State Library of Iowa.